Skip to main content
Erschienen in: Indian Journal of Gastroenterology 3/2011

01.05.2011 | Original Article

Prevalence and risk factors for gastroesophageal reflux in pregnancy

verfasst von: Bhavadharini Ramu, Pazhanivel Mohan, Muthu Subramanian Rajasekaran, Venkataraman Jayanthi

Erschienen in: Indian Journal of Gastroenterology | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Background and aim

Prevalence of gastroesophageal reflux (GER) increases during pregnancy, due to several factors like decreased lower esophageal sphincter pressure, increased intra-abdominal pressure secondary to the enlarged gravid uterus and alteration in gastrointestinal transit. The present study aimed to determine the prevalence of GER in pregnancy in a southern State of the Indian subcontinent and determine the risk factors associated with it.

Methods

Consecutive pregnant females (n = 400) at various stages of pregnancy attending the antenatal clinic or admitted in the antenatal wards were enrolled. Patients with heartburn or regurgitation or both (n = 182) for at least a week were defined as cases, and controls were those without these symptoms (n = 218). Data on demographic variables and symptoms were analyzed using Pearson chi-square, Yates corrected chi-square and Fischer exact test and student independent t-test as appropriate; p < 0.05 was considered significant.

Results

Demographic characteristics between cases and controls were similar. The mean age of cases (23.68±3.37 years) was similar to that of controls (23.25±3.31 years). The overall prevalence of GER was 45.5% (182/400), 77 (19.3%) had heartburn (GER-HB), 54 (13.5%) had regurgitation (GER-R) and 51 (12.8%) had both (GER-HB + R). Age and gravida did not influence the frequency of symptoms. Symptoms were more frequent in the second (43.1%) and third trimester (54.1%) as compared to the first trimester (9.5%) in pregnant women with GER (p < 0.001). Atypical symptoms were uncommon. GER was common among non-vegetarians (p = 0.02) and frequent aerated beverage users (p = 0.001).

Conclusions

GER prevalence was high in pregnancy, often in second and third trimester. Non-vegetarianism and aerated beverages increased the risk of reflux in pregnancy.
Literatur
1.
Zurück zum Zitat Bassy O. Pregnancy and heartburn in Nigerians and Caucasians with theories about aetiology based on manometric recordings from the oesophagus and stomach. Br J Obstet Gynaecol. 1977;84:439–43.CrossRef Bassy O. Pregnancy and heartburn in Nigerians and Caucasians with theories about aetiology based on manometric recordings from the oesophagus and stomach. Br J Obstet Gynaecol. 1977;84:439–43.CrossRef
2.
Zurück zum Zitat Barr W. Heartburn in pregnancy. J Obstet Gynaecol Br Emp. 1958;65:1019–21.CrossRef Barr W. Heartburn in pregnancy. J Obstet Gynaecol Br Emp. 1958;65:1019–21.CrossRef
3.
Zurück zum Zitat Bainbridge ET, Temple JG, Nicholas SP, et al. Symptomatic gastro-esophageal reflux in pregnancy: a comparative study of white Europeans and Asians in Birmingham. Br J Clin Pract. 1983;37:53–7.PubMed Bainbridge ET, Temple JG, Nicholas SP, et al. Symptomatic gastro-esophageal reflux in pregnancy: a comparative study of white Europeans and Asians in Birmingham. Br J Clin Pract. 1983;37:53–7.PubMed
4.
Zurück zum Zitat Goh KL. Changing epidemiology of gastroesophageal reflux disease in the Asian-Pacific region: an overview. J Gastroenterol Hepatol. 2004;19 Suppl 3:22–5.CrossRef Goh KL. Changing epidemiology of gastroesophageal reflux disease in the Asian-Pacific region: an overview. J Gastroenterol Hepatol. 2004;19 Suppl 3:22–5.CrossRef
5.
Zurück zum Zitat Bor S, Kitapcioglu G, Dettmar P, Baxter T. Association of heartburn during pregnancy with the risk of gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2007;5:1035–9.PubMedCrossRef Bor S, Kitapcioglu G, Dettmar P, Baxter T. Association of heartburn during pregnancy with the risk of gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2007;5:1035–9.PubMedCrossRef
6.
Zurück zum Zitat Wu JC. Gastroesophageal reflux disease: an Asian perspective. J Gastroenterol Hepatol. 2008;23:1785–93.PubMedCrossRef Wu JC. Gastroesophageal reflux disease: an Asian perspective. J Gastroenterol Hepatol. 2008;23:1785–93.PubMedCrossRef
7.
Zurück zum Zitat Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005;54:710–7.PubMedCrossRef Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005;54:710–7.PubMedCrossRef
8.
Zurück zum Zitat Fock KM, Talley NJ, Fass R, et al. Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. J Gastroenterol Hepatol. 2008;23:8–22.PubMedCrossRef Fock KM, Talley NJ, Fass R, et al. Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. J Gastroenterol Hepatol. 2008;23:8–22.PubMedCrossRef
9.
Zurück zum Zitat Sharma PK, Ahuja V, Madan K, Raizada A, Sharma MP. Prevalence of symptomatic GERD: interim analysis of an adult community-based cross-sectional study. Indian J Gastroenterol. 2004;23 Suppl 2:A11. Sharma PK, Ahuja V, Madan K, Raizada A, Sharma MP. Prevalence of symptomatic GERD: interim analysis of an adult community-based cross-sectional study. Indian J Gastroenterol. 2004;23 Suppl 2:A11.
10.
Zurück zum Zitat Kumar S, Karthik Selvaraj M, Jayanthi V. Prevalence of symptoms of gastro-esophageal reflux amongst medical students. Indian J Gastroenterol. 2006;25:168–9. Kumar S, Karthik Selvaraj M, Jayanthi V. Prevalence of symptoms of gastro-esophageal reflux amongst medical students. Indian J Gastroenterol. 2006;25:168–9.
11.
Zurück zum Zitat Jayanthi V. Severity of esophagitis in southern Indians. Indian J Gastroenterol. 2002;21:205.PubMed Jayanthi V. Severity of esophagitis in southern Indians. Indian J Gastroenterol. 2002;21:205.PubMed
12.
Zurück zum Zitat Ho KY, Kang JY, Viegas OA. Symptomatic gastro-oesophageal reflux in pregnancy: a prospective study among Singaporean women. J Gastroenterol Hepatol. 1998;13:1020–6.PubMedCrossRef Ho KY, Kang JY, Viegas OA. Symptomatic gastro-oesophageal reflux in pregnancy: a prospective study among Singaporean women. J Gastroenterol Hepatol. 1998;13:1020–6.PubMedCrossRef
13.
Zurück zum Zitat Marrero JM, Goggin PM, de Caestecker JS, Pearce JM, Maxwell JD. Determinants of pregnancy heartburn. Br J Obstet Gynaecol. 1992;99:731–4.PubMedCrossRef Marrero JM, Goggin PM, de Caestecker JS, Pearce JM, Maxwell JD. Determinants of pregnancy heartburn. Br J Obstet Gynaecol. 1992;99:731–4.PubMedCrossRef
14.
Zurück zum Zitat Rey E, Rodriguez-Artalejo F, Herraiz MA et al. Gastroesophageal reflux symptoms during and after pregnancy: a longitudinal study. Am J Gastroenterol. 2007;102:2395–400. Rey E, Rodriguez-Artalejo F, Herraiz MA et al. Gastroesophageal reflux symptoms during and after pregnancy: a longitudinal study. Am J Gastroenterol. 2007;102:2395–400.
15.
Zurück zum Zitat Klauser AF, Schindlbeck NE, Muller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet. 1990;335:205–8.PubMedCrossRef Klauser AF, Schindlbeck NE, Muller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet. 1990;335:205–8.PubMedCrossRef
16.
Zurück zum Zitat Andersen LI, Madsen PV, Dalgaard P, Jensen G. Validity of clinical symptoms in benign esophageal disease, assessed by questionnaire. Acta Med Scand. 1987;221:171–7.PubMedCrossRef Andersen LI, Madsen PV, Dalgaard P, Jensen G. Validity of clinical symptoms in benign esophageal disease, assessed by questionnaire. Acta Med Scand. 1987;221:171–7.PubMedCrossRef
17.
Zurück zum Zitat Baron TH. Gastrointestinal motility disorders during pregnancy. Ann Intern Med. 1993;118:366–75.PubMed Baron TH. Gastrointestinal motility disorders during pregnancy. Ann Intern Med. 1993;118:366–75.PubMed
18.
Zurück zum Zitat Al Amri SM. Twenty-four hour pH monitoring during pregnancy and at postpartum: a preliminary study. Eur J Obstet Gynaecol Reprod Biol. 2002;102:127–30. Al Amri SM. Twenty-four hour pH monitoring during pregnancy and at postpartum: a preliminary study. Eur J Obstet Gynaecol Reprod Biol. 2002;102:127–30.
19.
Zurück zum Zitat Klinkenberd-Knoll E, Castell DO. Clinical spectrum and diagnosis of gastroesophageal reflux disease. In: Castell DO, editor. The Esophagus. Boston: Little, Brown and Co.; 1993. p. 441–8. Klinkenberd-Knoll E, Castell DO. Clinical spectrum and diagnosis of gastroesophageal reflux disease. In: Castell DO, editor. The Esophagus. Boston: Little, Brown and Co.; 1993. p. 441–8.
Metadaten
Titel
Prevalence and risk factors for gastroesophageal reflux in pregnancy
verfasst von
Bhavadharini Ramu
Pazhanivel Mohan
Muthu Subramanian Rajasekaran
Venkataraman Jayanthi
Publikationsdatum
01.05.2011
Verlag
Springer-Verlag
Erschienen in
Indian Journal of Gastroenterology / Ausgabe 3/2011
Print ISSN: 0254-8860
Elektronische ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-010-0067-3

Weitere Artikel der Ausgabe 3/2011

Indian Journal of Gastroenterology 3/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.